Patient Selection and Timing Considerations for CAR T Therapy

Experts discuss patient selection and timing considerations for chimeric antigen receptor T-cell (CAR T) therapy in treating relapsed/refractory large B-cell lymphoma.

EP: 1.Brief Overview of Current Treatment Landscape and Unmet Needs in R/R Large B-Cell Lymphoma

EP: 2.Three-Year Follow-Up From Phase 3 TRANSFORM: Study Overview and Key Efficacy Data

EP: 3.Long-Term Efficacy and Real-World Outcomes With Liso-cel

Now Viewing

EP: 4.Patient Selection and Timing Considerations for CAR T Therapy

Recent Videos